MARKETS / TNBI
GRAIN MILL PRODUCTS
Tanke Biosciences Corp. TNBI
4 fiscal years on record · USD · FY2012 reported · SEC filings only
Growth
USD 28.6M
Revenue, FY2012 · full 4-year series below
Revenue $M
Net income $M
FY2012 · Revenue 28.6 · Net income -0.2
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
−1 cents
lost on every revenue dollar
Operating margin
Net margin
FY2012 · Operating 15.9% · Net -0.8%
ROE
FY2012 · ROE -1.3%
Each USD of equity lost 1 cents this year.
The 4-year record
4 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
| Metric | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|
| Revenue $B | 0.0 | 0.0 | 0.0 | · |
| Operating income $B | 0.0 | 0.0 | 0.0 | · |
| EBITDA $B | 0.0 | 0.0 | 0.0 | · |
| Income tax $B | 0.0 | 0.0 | 0.0 | · |
| Net income $B | −0.0 | −0.0 | 0.0 | 0.0 |
| Free cash flow $B | −0.0 | 0.0 | 0.0 | · |
| EPS, diluted $ | −0.02 | −0.24 | 0.34 | · |
| Dividend / sh $ | · | · | · | · |
| Payout % | · | · | · | · |
| ROE % | −1.3 | −26.1 | 33.5 | · |
| Shares out B | 0.01 | 0.01 | 0.01 | · |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Provenance
Company facts, as filed
How we verify · 0 failures in 16 reconciliationsAUDITED
Reconciled in 4 of 19 fiscal years. 79 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityGrain Mill Products
Listed onnot stated in the filings
Incorporated inNevada
Fiscal year endsDecember 31
Data on record since2009